NanoString Technologies, Inc. – NASDAQ:NSTG
Financial Health
0
1
2
3
4
5
6
7
8
9
Market open
Closed in about 3 hours
NanoString Technologies stock price monthly change
-41.18%
month
NanoString Technologies stock price quarterly change
-56.96%
quarter
NanoString Technologies stock price yearly change
-98.82%
year
NanoString Technologies key metrics
Market Cap | 5.06M |
Enterprise value | 611.88M |
P/E | -3.09 |
EV/Sales | 4.80 |
EV/EBITDA | -4.26 |
Price/Sales | 3.72 |
Price/Book | 10.33 |
PEG ratio | 0.08 |
EPS | -3.53 |
Revenue | 162.47M |
EBITDA | -155.10M |
Income | -166.43M |
Revenue Q/Q | 62.78% |
Revenue Y/Y | 20.08% |
Profit margin | -125.37% |
Oper. margin | -119.58% |
Gross margin | 48.55% |
EBIT margin | -119.58% |
EBITDA margin | -95.47% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeNanoString Technologies stock price history
NanoString Technologies stock forecast
NanoString Technologies financial statements
| Dec 2022 | 34.42M | -44.11M | -128.16% |
|---|---|---|---|
| Mar 2023 | 35.80M | -41.23M | -115.17% |
| Jun 2023 | 44.15M | -43.66M | -98.89% |
| Sep 2023 | 48.08M | -37.41M | -77.8% |
| Jun 2023 | 44.15M | -43.66M | -98.89% |
|---|---|---|---|
| Sep 2023 | 48.08M | -37.41M | -77.8% |
| Sep 2025 | 62.44M | -17.10M | -27.39% |
| Dec 2025 | 68.03M | -15.98M | -23.49% |
Analysts Price target
Financials & Ratios estimates
| 2024-02-27 | -0.47 | -0.95 |
|---|
0%
Yield TTM
| Payout ratio | 0% |
|---|
| 2018 | 16.09% |
|---|---|
| 2019 | |
| 2020 | |
| 2021 | |
| 2022 |
| Dec 2022 | 353412000 | 307.59M | 87.04% |
|---|---|---|---|
| Mar 2023 | 320415000 | 306.79M | 95.75% |
| Jun 2023 | 288990000 | 310.45M | 107.43% |
| Sep 2023 | 274713000 | 325.27M | 118.41% |
| Dec 2022 | -28.08M | 24.11M | -1.28M |
|---|---|---|---|
| Mar 2023 | -35.74M | 43.79M | 814K |
| Jun 2023 | -31.44M | 24.30M | 36K |
| Sep 2023 | -19.69M | -1.91M | 822K |
NanoString Technologies alternative data
| Aug 2023 | 703 |
|---|---|
| Sep 2023 | 703 |
| Oct 2023 | 703 |
| Nov 2023 | 703 |
| Dec 2023 | 550 |
| Jan 2024 | 550 |
| Feb 2024 | 550 |
| Mar 2024 | 550 |
| Apr 2024 | 550 |
| May 2024 | 550 |
| Jun 2024 | 550 |
| Jul 2024 | 550 |
NanoString Technologies other data
96.00%
-4.00%
of NSTG is owned by hedge funds
139
-16
44.57M
-3.97M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jun 2022 | 0 | 1945 |
| Dec 2022 | 96822 | 0 |
| Mar 2023 | 24500 | 0 |
| May 2023 | 80400 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Option | GRAY R BRADLEY director, officer.. | Restricted Stock Units | 236,364 | N/A | N/A | ||
Option | GRAY R BRADLEY director, officer.. | Performance Restricted Stock Units | 354,545 | N/A | N/A | ||
Option | MALLOY KIRK director | Common Stock | 41,133 | N/A | N/A | ||
Option | MALLOY KIRK director | Restricted Stock Units | 41,133 | N/A | N/A | ||
Option | YOUNG WILLIAM director | Common Stock | 41,133 | N/A | N/A | ||
Option | YOUNG WILLIAM director | Restricted Stock Units | 41,133 | N/A | N/A | ||
Option | FINNEY ELISHA W director | Common Stock | 41,133 | N/A | N/A | ||
Option | FINNEY ELISHA W director | Restricted Stock Units | 41,133 | N/A | N/A | ||
Option | BAILEY K THOMAS officer: Chief Financial Officer | Common Stock | 8,460 | N/A | N/A | ||
Option | BEECHEM JOSEPH M officer: SVP, Res.. | Common Stock | 34,848 | N/A | N/A |
| Patent |
|---|
Application Filling date: 28 Mar 2022 Issue date: 14 Jul 2022 |
Application Filling date: 21 Mar 2022 Issue date: 7 Jul 2022 |
Grant Filling date: 4 Sep 2019 Issue date: 22 Mar 2022 |
Application METHODS, APPARATUSES, SYSTEMS AND DEVICES FOR MOBILE DIGITAL SPATIAL PROFILING OF PATHOLOGICAL SPECIMENS Filling date: 20 Dec 2019 Issue date: 10 Mar 2022 |
Application Filling date: 16 Sep 2021 Issue date: 30 Dec 2021 |
Application Filling date: 16 Sep 2021 Issue date: 30 Dec 2021 |
Application Filling date: 20 May 2019 Issue date: 25 Nov 2021 |
Grant Filling date: 11 Feb 2019 Issue date: 24 Aug 2021 |
Application Filling date: 2 Nov 2020 Issue date: 1 Jul 2021 |
Application Filling date: 6 Feb 2020 Issue date: 8 Oct 2020 |
| Quarter | Transcript |
|---|---|
| Q3 2023 6 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 3 Aug 2023 | Q2 2023 Earnings Call Transcript |
| Q1 2023 3 May 2023 | Q1 2023 Earnings Call Transcript |
| Q4 2022 28 Feb 2023 | Q4 2022 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
| Mr. R. Bradley Gray (1977) Chief Executive Officer, Pres & Director | $1,140,000 |
Mr. K. Thomas Bailey M.B.A. (1969) Chief Financial Officer | $638,160 |
| Dr. Joseph M. Beechem (1958) Chief Scientific Officer and Senior Vice President of R&D | $615,920 |
| Mr. J. Chad Brown (1958) Senior Vice President of Sales & Marketing | $612,990 |
| Mr. David W. Ghesquiere (1967) Senior Vice President of Corporation & Bus. Devel. | $598,610 |
-
When is NanoString Technologies's next earnings date?
Unfortunately, NanoString Technologies's (NSTG) next earnings date is currently unknown.
-
Does NanoString Technologies pay dividends?
No, NanoString Technologies does not pay dividends.
-
How much money does NanoString Technologies make?
NanoString Technologies has a market capitalization of 5.06M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 12.28% to 127.26M US dollars. NanoString Technologies made a loss 159.54M US dollars in net income (profit) last year or -$0.95 on an earnings per share basis.
-
What is NanoString Technologies's stock symbol?
NanoString Technologies, Inc. is traded on the NASDAQ under the ticker symbol "NSTG".
-
What is NanoString Technologies's primary industry?
Company operates in the Healthcare sector and Medical - Instruments & Supplies industry.
-
How do i buy shares of NanoString Technologies?
Shares of NanoString Technologies can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are NanoString Technologies's key executives?
NanoString Technologies's management team includes the following people:
- Mr. R. Bradley Gray Chief Executive Officer, Pres & Director(age: 48, pay: $1,140,000)
- Mr. K. Thomas Bailey M.B.A. Chief Financial Officer(age: 56, pay: $638,160)
- Dr. Joseph M. Beechem Chief Scientific Officer and Senior Vice President of R&D(age: 67, pay: $615,920)
- Mr. J. Chad Brown Senior Vice President of Sales & Marketing(age: 67, pay: $612,990)
- Mr. David W. Ghesquiere Senior Vice President of Corporation & Bus. Devel.(age: 58, pay: $598,610)
-
How many employees does NanoString Technologies have?
As Jul 2024, NanoString Technologies employs 550 workers.
-
When NanoString Technologies went public?
NanoString Technologies, Inc. is publicly traded company for more then 12 years since IPO on 26 Jun 2013.
-
What is NanoString Technologies's official website?
The official website for NanoString Technologies is nanostring.com.
-
Where are NanoString Technologies's headquarters?
NanoString Technologies is headquartered at 530 Fairview Avenue North, Seattle, WA.
-
How can i contact NanoString Technologies?
NanoString Technologies's mailing address is 530 Fairview Avenue North, Seattle, WA and company can be reached via phone at +20 63 786266.
NanoString Technologies company profile:
NanoString Technologies, Inc.
nanostring.comExchange:
NASDAQ
Full time employees:
550
Industry:
Medical - Instruments & Supplies
Sector:
Healthcare
NanoString Technologies, Inc. develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers Master Kits, such as ancillary reagents and plasticware to setup and process samples in the nCounter Prep Station and nCounter Digital Analyzer; and Prosigna molecular diagnostic test kits. The company is also developing GeoMx DSP system to enable the field of spatial genomics. It has collaboration with Lam Research Corporation for the research and development of Hyb & Seq technologies; Celgene Corporation for developing LymphMark, an in vitro diagnostic for the treatment of diffuse large B-cell lymphoma; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer. NanoString Technologies, Inc. was incorporated in 2003 and is headquartered in Seattle, Washington.
530 Fairview Avenue North
Seattle, WA 98109
Seattle, WA 98109
CIK: 0001401708
ISIN: US63009R1095
CUSIP: 63009R109
